Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
absenteeism, Answer, Call, CECL, cellular, closure, Complaint, Craig, Cunningham, District, Eastern, Governor, ill, indeterminable, infected, lawsuit, notwithstanding, outbreak, paragraph, phone, physical, pronouncement, rapidly, Registry, reorganized, residential, sending, spread, team, telemarketing, text, underperformance, world, worsen, wrote
Removed:
adjustment, approximate, arrangement, assessment, campaign, complexity, Cuddihy, diversified, diversity, end, favor, flow, fully, grow, inclusive, initiate, introduce, John, Jr, lead, lien, lifetime, lump, noted, presence, profitably, promissory, replacement, representing, resignation, restricted, Robert, satisfactory, secured, simultaneously, tested, TV, variable
Filing tables
Filing exhibits
PRPH similar filings
Filing view
External links
EXHIBIT 21.1
SUBSIDIARIES OF PROPHASE LABS, INC.
State or other | ||||
Jurisdiction of | Ownership | |||
Subsidiaries | Incorporation | Percentage | ||
Pharmaloz Manufacturing Inc. | Delaware | 100 % | ||
Phusion Labs Manufacturing, Inc. | Delaware | 100 % | ||
ProPhase Digital Media, Inc. | Delaware | 100 % | ||
Quigley Pharma Inc. | Delaware | 100 % | ||
TK Supplements, Inc. | Delaware | 100 % |
The above subsidiaries are included in the consolidated financial statements for the year ended December 31, 2019.